Literature DB >> 12959430

Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997.

Jill S Barnholtz-Sloan1, Andrew E Sloan, Ann G Schwartz.   

Abstract

OBJECT: The purpose of this study was to examine patterns of diagnosis and relative survival rates in individuals in whom a primary malignant brain tumor was diagnosed between 1973 and 1997; follow-up review of these patients continued through the end of 1999.
METHODS: The study population was composed of 21,493 patients with primary malignant brain tumors that were diagnosed between 1973 and 1997. Data on these patients were obtained from the population-based Surveillance, Epidemiology, and End Results Program. The study population was divided into three cohorts based on the year of diagnosis, and these groups were compared with respect to variables of interest by performing chi-square tests and relative survival analysis with the life table method. Over time, there were consistently more men, more Caucasians, more patients undergoing surgery, and more individuals 70 years and older who received the diagnosis of primary malignant brain tumor. An examination of proportions of individuals with astrocytoma, other; oligodendroglioma, other; and oligodendroglioma Grade III showed significant temporal changes with frontal and temporal lobe tumors occurring most often. The diagnosis was obtained at an earlier age in African-American than in Caucasian patients. Caucasians had higher proportions of glioblastoma multiforme (GBM), which was associated with decreased survival times, and of oligodendroglioma, other, whereas African Americans had higher proportions of astrocytoma, other; ependymoma Grade II or III; and medulloblastoma, all of which were associated with increased survival times. The relative survival case demonstrated a continuous improvement over time, although older patients, those who underwent biopsy only, and those with GBMs continue to have the poorest survival times. The relative survival rates of African Americans consistently were similar or worse than those of Caucasians when the groups were stratified by prognostic factors.
CONCLUSIONS: Over time, the relative survival rate of individuals with primary malignant brain tumor has improved and differences in survival are seen by examining the race of the patients.

Entities:  

Mesh:

Year:  2003        PMID: 12959430     DOI: 10.3171/jns.2003.99.3.0458

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  33 in total

1.  Population-based survival data for brain tumors in Korea.

Authors:  Kyu-Won Jung; Heon Yoo; Hyun-Joo Kong; Young-Joo Won; Sohee Park; Seung Hoon Lee
Journal:  J Neurooncol       Date:  2012-06-04       Impact factor: 4.130

2.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

3.  Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.

Authors:  Hongyu Zhao; Weisong Cai; Shitao Su; Debao Zhi; Jie Lu; Shuo Liu
Journal:  Tumour Biol       Date:  2013-12-18

Review 4.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

5.  Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Authors:  Amy S Darefsky; Joseph T King; Robert Dubrow
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

Review 6.  The role of unconscious bias in surgical safety and outcomes.

Authors:  Heena P Santry; Sherry M Wren
Journal:  Surg Clin North Am       Date:  2011-12-06       Impact factor: 2.741

7.  Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.

Authors:  Ryuichi Kanai; Cecile Zaupa; Donatella Sgubin; Slawomir J Antoszczyk; Robert L Martuza; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

8.  Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.

Authors:  Masahide Matsuda; Keisuke Nimura; Takashi Shimbo; Toshimitsu Hamasaki; Tetsuya Yamamoto; Akira Matsumura; Yasufumi Kaneda
Journal:  J Neurooncol       Date:  2010-08-22       Impact factor: 4.130

9.  Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.

Authors:  M Matsuda; T Yamamoto; E Ishikawa; K Nakai; A Zaboronok; S Takano; A Matsumura
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

10.  Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism.

Authors:  Meijing Wu; Jason Miska; Ting Xiao; Peng Zhang; J Robert Kane; Irina V Balyasnikova; James P Chandler; Craig M Horbinski; Maciej S Lesniak
Journal:  J Neurooncol       Date:  2019-01-31       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.